Antibacterial resistance has become a serious crisis for world health over the last few decades, so that new therapeutic approaches are strongly needed to face the threat of resistant infections.
Introduction
The emergence of drug-resistant microbial strains is a natural phenomenon that occurs when bacteria evolve and adapt to face the threats posed by antimicrobial agents [1] . However, this process has been greatly accelerated by the excessive and incorrect use of antibacterial drugs. This has resulted in the lack of available treatments for once curable infectious diseases [2, 3] , determining a world-wide health crisis as reported by the World Health Organization [4] . In this context, renewed interest by public and private initiatives has focused on innovative approaches [5] . Among several alternative approaches proposed [6] [7] [8] [9] [10] [11] , transcription factor decoys (TFD) have shown the potential to defeat resistant infections, such as those caused by Clostridium difficile in animal models [12] , when combined with a bolaamphiphilic cationic delivery molecule (12-bis-THA) to form nanosized association complexes, termed nanoplexes.
TFDs are short oligonucleotides consisting of base sequences that mimic the binding site to transcription factors, and they can block essential genetic pathways in bacteria, thereby preventing their survival response against antimicrobial attack [13] . The cationic surfactant 12-bis-THA is a bolaamphiphile with a molecular structure reminiscent of dequalinium, which is prescribed as a topical treatment for various bacterial infections. Besides its intrinsic antibacterial activity, owing to the positive electrostatic charge, dequalinium has been studied as a scaffold for gene delivery systems [14] . Similarly, 12-bis-THA plays a fundamental role in forming nanoplexes with oligonucleotides, which are condensed into a psi-form [15] : this structural rearrangement affords both resistance to DNA degradation [16] and DNA delivery into live cells [17] . The condensation process is reversible, as the fully renatured oligonucleotide can be released from the complex with 12-bis-THA by displacing it with a competing anionic molecule [15] .
12-bis-THA/TFD nanoplexes have been shown to be active in animal studies [17] , but it is known that their colloidal stability needs to be improved prior to preclinical development, as they have the tendency to form insoluble precipitates in conditions of physiological ionic strength. The
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4 optimized delivery system would also have controllable physical-chemical properties, as these affect the biodistribution of the nanoplexes and thus which infections can be treated. All of these requirements can be met by liposomes (or small unilamellar vesicles, SUV): these can be formulated from biocompatible lipids, and they have been successfully used as drug carriers [18] and transfection vectors [19] . In particular, several antibiotics already commercially distributed are formulated on a liposomal scaffold [20] , and liposomes have been proposed as antisense DNA vectors to bacteria [21] .
In the present work, we redesigned the 12-bis-THA/TFD antimicrobial complex in a stable liposomal formulation that can retain delivery to the bacterial cytoplasm. Given the amphiphilic nature of 12-bis-THA, the encapsulation of nanoplexes in liposomes poses some challenges. A physical-chemical study was therefore necessary to assess the possible influence of the payload on liposomal stability and bilayer integrity [22, 23] . Therefore, we first investigated the effect of 12-bis-THA on the structure of liposomes based on classic lipids, i.e. neat POPC or a POPC/DOPE mixture; next, the formulations were investigated in depth to elucidate the nanoscale features of the bilayer, focusing in particular on the POPC/DOPE scaffolds. A preliminary biological evaluation was carried out to assess the transfection ability to model bacteria, the antibacterial activity and the cytotoxicity of these promising formulations.
Materials and methods

Materials
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and DOPE (1,2-dioleoyl-snglycero-3-phosphoethanolamine) were purchased from Avanti PolarLipids (Alabaster, AL).
12-bis-THA (1,1'-(dodecane-1,12-diyl)-bis-(9-amino-1,2,3,4-tetrahydroacridinium) (chloride or iodide) was synthesized by Shanghai Chempartners & co. LTD.
Ultrapure water was obtained by means of a Millipore Elix® 3 water purification system.
Oligonucleotide synthesis
The oligonucleotide TFDs used in this work were manufactured and purified through HPLC at AxoLabs (Kulmbach, Germany). The TFD used for structural studies has been described elsewhere [15] ; it consists of 77 base pairs containing the binding site for the sigma factors of RNA polymerase SigH. The fluorescently labeled Alexa488-Fur TFD was used in imaging and biological assays and contained the binding site for E. coli Fur transcription factor. Its sequence was: 5'-Alexa488-TEG-CGA TAG AAG TGG ATT TTT CCA CTT CTA* T*C*G-3', where TEG is a tetraethyl glycol linker and the last nucleotides followed by an asterisk contain a phosphorothioate backbone.
Stability of 12-bis-THA/TFD nanoplexes
To prepare 12-bis-THA/TFD nanoplexes in water, 500 µL of a water stock solution of 12-bis-THA at a concentration of 0.23 mg/mL were mixed with 490 µL H2O and vortexed for 30 s. Then, 10 µl of TFD aqueous solution (1 mg/mL) were added, and vortexed for 30 s more. The nanoplexes thereby obtained were characterized by a positive-to-negative charge ratio Z+/-= 11.
To prepare particles in saline solutions, 500 µL of a water stock solution of 12-bis-THA at a concentration of 0.23 mg/mL were mixed with 390 µL H2O and vortexed for 30 s. Then, 10 µl of
TFD aqueous solution (1 mg/mL) were added, and vortexed for 30 s more. Finally, 100 µL of 1.5 mol/L solutions of sodium chloride (NaCl) and sodium citrate (Na3Cit) were added to the particle solution.
Preparation of multilamellar vesicles and liposomes
The lipids POPC and DOPE were weighed in order to obtain a POPC:DOPE = 7:3 weight ratio, in such a way as to obtain a final total concentration of 5 mg/mL lipids in the liposomal suspensions. The lipids were firstly dissolved and thoroughly mixed in chloroform or chloroform/methanol. The solvent was evaporated using a gentle N2 flow, and the lipid films were further dried by vacuum pumping for at least 8 hours. The films were hydrated with water or with a TFD solution, depending on the particular protocol, and the mixture was vortexed to obtain a suspension of multilamellar vesicles. In a typical sample, the lipids-to-12-bis-THA mole ratio would be 20:1, while the mole ratio between the bolaamphiphile and the oligonucleotide would be 860:1 (which affords Z+/-= 11), unless specified differently.
In order to obtain liposomes, the mixture underwent ten freeze-and-thaw cycles (from liquid nitrogen to a 50 °C water bath), unless the oligonucleotide was already present. Eventually, the suspension was extruded ten times through a polycarbonate filter (pore size = 100 nm). If 12-bis-THA was not in the initial dry film, it would be incorporated in the liposomes by a surface decoration method as follows: the bolaamphiphile was dissolved in methanol, then a dry film was obtained by evaporating the solvent under N2, and the appropriate amount of liposomal dispersion was poured on top of the dry film. The sample was vortexed and then kept in orbital stirring for approximately 10 hours.
12-bis-THA quantification in liposomes
The concentration of 12-bis-THA in the liposomes was ascertained by HPLC analysis, using a Zorbax Eclipse XDB-C18 column (150 u 4.6 mm, 5 µm). The chromatography was carried out at 
TFD quantification in liposomes
The TFD concentration in liposomes was assessed using the Quant-iT™ OliGreen® fluorescent DNA staining dye (Life Technologies). A fluorescence intensity vs. TFD concentration standard curve was realized by recording the emission spectra of OliGreen® on a LS50B spectrofluorimeter (Perkin-Elmer, Italy); the spectra were acquired in the corrected mode, with an excitation wavelength of 480 nm and 10 nm slits, and the intensity at the emission maximum (520 nm) was plotted against [TFD] . Liposomal samples were diluted appropriately to fit in the linear range. The amount of TFD encapsulated in the liposomes was estimated by measuring the fluorescence of the OliGreen dye before and after the disruption of liposomes with 1 wt% Triton X-100. For each sample, 3 acquisitions were collected at 25 °C and averaged.
Differential scanning calorimetry (DSC)
DSC analysis was performed with a Q2000 DSC, TA Instruments (New Castle, USA). Roughly 30 mg of each sample were placed in aluminum hermetic pans and analyzed scanning the temperature between 0 °C and 50 °C at 5 ºC/min.
Dynamic light scattering (DLS)
DLS analysis was used to infer the size and polydispersity of 12-bis-THA/TFD nanoplexes and of liposomes. For the nanoplexes, a Malvern ZetaSizer ZS was used, having a red laser (λ = 630 nm) and the detector placed at 173°. For the liposomes, the instrument used was a Brookhaven BI9000-AT digital autocorrelator, equipped with a green laser (λ = 532 nm; Torus, mpc3000, LaserQuantum, UK) and an APD detector placed at 90°. In both cases, the hydrodynamic
diameters were calculated by cumulant analysis of the autocorrelation functions to extract the diffusion coefficients of the dispersed particles, which were then converted into sizes by assuming a spherical shape via the Stokes-Einstein equation.
Zeta-potential measurements
ζ-potentials were obtained from phase analysis light scattering (PALS) analysis, performed on a Brookhaven ZetaPALS instrument, equipped with a laser operating at 659 nm. The scattered intensity was collected at 15° to determine the electrophoretic mobility; the ζ-potentials were then calculated through the Helmholtz-Smoluchowski equation.
Small angle x-ray scattering (SAXS)
SAXS analysis of multilamellar vesicles was carried out with a Kratky camera system Data reduction and background subtraction were performed with the software IGOR Pro (Wavemetrics, Inc.) [24] . Curves obtained with the Kratky camera were iteratively desmeared using the procedure reported by Lake [25] . Data modelling was carried out with the software GAP, provided by Prof. Georg Pabst (Graz University, Austria) [26] .
Confocal laser scanning microscopy (CLSM)
E. coli strain DH5α was grown to mid-log growth (Optical Density 0.2 -0.3 at 630 nm) in LB broth. Fresh culture was mixed with an equal volume of liposomes loaded with an Alexa-Fluor488-labelled TFD (λ ex488/em519) and incubated at room temperature for a total of 1.5 hours, under constant agitation in the dark. For the last 30 minutes, the bacterial membrane was labelled with the fluorescent membrane dye WGA-TMR (λ ex555/em580 nm, Life Technologies, UK) at a final concentration of 10 µg/ml. The samples were smeared onto poly-L-lysine coated slides (SigmaAldrich, UK) and incubated for a further 1 hour in the dark at room temperature. Slides were then gently washed with filtered-sterilized PBS and dried in the air. Microscopy slides were kept in the dark at 4 °C prior to analysis by confocal microscopy using either a Leica TCS SP5 confocal microscope or a Leica TCS SP2, using a 63u oil immersion objective or a 63u water immersion objective, respectively. In both cases, the images were acquired with 488 nm Argon laser excitation (λ em498/ex530 nm) for Alexa488-labeled TFD and with DPSS 561 nm laser excitation (λ em571/ex620 nm) for WGA-TMR dye labeling the bacterial membrane.
Biological assays
Brief experimental methods for three biological assays are included below. Further details can be found in the Supplementary Methods section.
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-Antibacterial activity (MIC test).
The antibacterial activity of 12-bis-THA−containing formulations was tested against Escherichia coli DH5α using standard procedures, where changes in the optical density (630 nm) after overnight growth is interpreted as bacterial growth inhibition.
Bacteria were incubated with liposomes in a concentration range between 5.3u10 -Xenopus laevis toxicity assay. All experiments were performed in compliance with the relevant laws and institutional guidelines at the University of East Anglia. The research has been approved by the local ethical review committee according to UK Home Office regulations. Xenopus laevis embryos were obtained as previously described [27] . X. laevis embryos at stage 38 were exposed to liposomes ± 12-bis-THA and TFD at concentrations ranging from 2.65u10 
Results and Discussion
We recently showed, using a range of complementary physical techniques, that 12-bis-THA (Scheme 1) complexes TFDs into a highly compacted, nuclease-resistant "psi" form in aqueous solution [15] . Scheme 1. Molecular structure of 12-bis-THA.
Here we studied the kinetics of nanoplex stability by dynamic light scattering (DLS), monitoring the variation of hydrodynamic diameter (DH) and average scattered intensity (Iav) in water and in saline media at physiological ionic strength. As illustrated in Figure 1A , nanoplexes in H2O stored at 4 °C were stable for at least 72 h in terms of size. The stability of particles in water at RT ( Figure 1B ) was limited to 24 h, when they were observed to become slightly larger;
in seven days, the size had increased by almost 100% while the scattering intensity was reduced by 7.5 times (data not shown). Indeed, since the light scattered by colloidal objects in solution is proportional to their concentration, such a dramatic decline of Iav clearly indicates the steep decrease of the number of suspended particles in solution as they progressively precipitate. The few particles remaining in suspension became larger over time due to coalescence and would most likely precipitate in time. Near instantaneous aggregation was observed after incubating the nanoplexes in saline solutions with physiological ionic strength (sodium citrate or sodium chloride, 150 mM). This phenomenon is expected, due to the electrostatic origin of colloidal stability in water. The screening of the electrostatic charge of ionic colloids in the presence of dissolved salts, according to the DLVO theory of colloidal stability, triggers aggregation and eventually precipitation [28] . At the same time, this denotes the marked instability of the 12-bis-THA/TFD antibacterial complex in saline media. In light of these results, we resorted to the reformulation of the 12-bis-THA/TFD nanoplexes in a lipid-based scaffold. 
Reformulation of nanoplexes into POPC-and POPC/DOPE liposomes
Liposomes for drug delivery are typically obtained with biocompatible lipids. We report here on the incorporation of 12-bis-THA and the loading of a model TFD in two lipid systems: one based on pure POPC and another based on the mixture of POPC and DOPE (1,2-dioleoyl-snglycero-3-phosphoethanolamine) in a 7:3 weight ratio. DOPE has been used for a long time as a helper lipid to promote fusion of liposomes with biological membranes, with proven ability to boost DNA transfection [29] and antibiotic efficacy [30] .
The symmetric bolaamphiphile 12-bis-THA is poorly soluble in water and does not behave like a typical surfactant, as it has no clear-cut critical micellar concentration [15] . However, the presence of two cationic headgroups along with a 12-C aliphatic chain spacer suggests the possibility of amphiphilic behaviour. In order to assess the effect of the bolaamphiphile on the integrity of lipid bilayers, we firstly incorporated 12-bis-THA into liposomes following two different paths. In the "co-extrusion method", 12-bis-THA (0.2 mM) was mixed with other lipids (5 mg/mL) in the initial dry film before hydration and membrane extrusion. In the "surface , and compared to the TFD content of the dispersion of multilamellar vesicles (MLV) before extrusion (see Figure S2 , Supporting Information). The assay yielded 84% (± 10%) of the theoretical TFD amount in the MLV dispersion after disruption of the membranes with Triton X-100, while in the extruded liposomes no DNA could be detected. This suggests that all the TFD was lost during the extrusion process.
Several hypotheses can be formulated to possibly explain the loss of material described above.
Firstly, DSC experiments ruled out the possible increase in the gel-to-fluid transition temperature,
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Tm, for the lipid bilayers. Indeed, no transition peaks were observed in the 4 °C -80 °C range (data not shown), which suggests that these lipid assemblies should be easily extruded at room temperature. In another possible scenario, the presence of both the TFD and 12-bis-THA in the initial lipid dry film may promote the formation of the strong complex between the two species directly in the hydrated bilayers, producing lipoplexes in a columnar phase, as observed in similar systems [31] . These species are often rigid and larger than 100 nm, with a greater propensity to obstruct the membrane pores, impeding the passage of the dispersion. In order to examine for such liquid-crystalline phases, we carried out a small-angle x-ray (SAXS) investigation of the POPC/DOPE MLV systems, without and with added bolaamphiphile or TFD, before extrusion. 
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16 which is a linear combination of the contributions S(Q) and P(Q) (form factor) weighed on the fraction Ndiff of positionally uncorrelated bilayers (i.e., unilamellar vesicles). The electron density of the lipid bilayer was modeled using three-Gaussian profiles [33] : two Gaussians represent the headgroups, centered at zH, and one Gaussian is used to represent the terminal −CH3 group at the bilayer's center. The procedure allowed us to determine the center zH and the width σH of the Gaussians representing the headgroups, and to calculate the bilayer thickness (i.e. the headgroupto-headgroup thickness of the lipid double-layer) as:
The salient structural features of a model bilayer, along with a typical electron density profile (ρ(z) as a function of the distance z from the bilayer center) are represented in Scheme 3, while fit results for the patterns in Figure 2 are displayed in Table 2 . For the POPC/DOPE system, we determined dB = 51 Å without TFD and dB = 52 Å with TFD.
Assuming the average headgroup thickness to be the weighted average of the phosphatidylcholine and phosphatidylethanolamine headgroups [34] , dH = 8.9 Å, through an elementary geometric deduction (Scheme 1) we obtain for half the hydrophobic region dC ≈ 16 Å. This value is comparable to what reported in the literature for POPC bilayers at 2 °C [35] , nevertheless, our calculated dC pertains to samples at 25 °C and is likely due to presence of 30% DOPE in the bilayer.
However, care must be taken when dealing with SAXS patterns where less than four Bragg peaks are present, as the resolution of the electron density profile is low [36] and it is not always possible to discern the exact threshold between headgroup and tail Gaussians.
The spectra pertaining to the samples containing also 12-bis-THA, with and without TFD ( Figure 2C,D) , are both consistent with the pure form factor P(Q) of non-interacting lipid bilayers,
i.e. only unilamellar vesicles are present. These form spontaneously upon incorporation of 12-bis-THA in the bilayer due to the positive charges of the bolaamphiphile molecules [37] , as the bilayer bends in order to minimize repulsion between neighbouring headgroups, and the formation of 
20
The spectra are all similar and they show both a structure factor and a form factor. This suggests the presence of residual oligolamellar vesicles (OLV), where the bilayers are in interaction with each other: OLV contribute greatly to the scattered radiation even when they are present in very small numbers. Only two Bragg reflections are observed, due to bilayer disorder originating from bending fluctuation in the fluid Lα phase (third kind-or Caillé disorder) [36] . For the liposomes with no TFD, the fit results presented in Table 3 indicate that the SAXS pattern is consistent with a maximum number of 2 interacting lamellae; such bi-lamellar vesicles are present in very low number, since the contribution of the diffuse scattering is Ndiff = 97% of the total I(Q). The bilayer thickness calculated with Equation 2 is dB = 48 Å, in agreement with previous results (Table 2) . In liposomes with 10 µg/mL TFD, the quality of the fitting was slightly poorer than for the spectrum of neat POPC/DOPE/12-bis-THA liposomes. Here, the number of interacting lamellae was constrained to 2 during the fitting procedure. The bilayer thickness obtained from the electron density profiles was 50 Å, which is 2 Å larger than the value obtained for the sample without TFD. at the poles and the septa of the bacteria. These are the areas of the E. coli membrane especially rich in cardiolipin [39] , a doubly-anionic lipid that is also present at high concentrations in the mitochondrial membrane of eukaryotic cells [40] . This result is in agreement with research involving the interaction of 12-bis-THA with model membranes [17] and the use of dequalinium as an efficient targeting system for mitochondria [41] . Moreover, a recent paper has demonstrated the key role of cardiolipin in the binding of cationic antimicrobial peptides and the perturbation of model bacterial membranes [42] , which strengthens even more the idea that the affinity of certain cationic antimicrobials for cardiolipin could be exploited as an active targeting mechanism.
However, the TFD release and delivery efficiency to the E. coli cytoplasm was low for POPC/12-bis-THA/TFD liposomes, with less than 2% of the visualized cells presenting a diffuse intracellular green signal compatible with intracellular TFD release. Therefore, the fusogenic DOPE lipid is a key component for maximized delivery of the TFD nanoplexes to the bacterial cell. A possible explanation may lie in the fact that the E. coli inner membrane is composed of > 80% phosphatidylethanolamine lipids [43, 44] .
Biological evaluation of liposomes
Liposomes based on the POPC/DOPE mixture were tested for their biological properties of interest, namely antibacterial activity and toxicity, in vitro and in vivo. To determine the activity of liposomal formulations on bacterial membranes a standard bacterial growth assay was used against the model Escherichia coli. As reported in Table 4 , both POPC/DOPE/12-bis-THA and POPC/DOPE/12-bis-THA/TFD liposomes showed similar antibacterial activity of 1.1 μmol/L (with reference to 12-bis-THA, see Figure S3 for corresponding growth curves), which compares with that of the bare nanoplex [17] . Hence, despite the differences seen in the CLSM results concerning the efficacy of delivery for the two formulations (Figure 4) , the membrane activity of the formulations was correlated to the concentration of 12-bis-THA.
The cytotoxicity of liposomal formulations was evaluated by measuring IC50 values with the MTT assay on Caco-2 intestinal epithelial cells (Table 4) In order to extend the toxicity profile of these formulations, the toxicity of the liposomal formulations was also assessed using the Xenopus laevis embryo model. This model can help to bridge the gap between traditional in vitro and preclinical mammalian assays in biomedical research and drug development. Animal models to be employed for organism-based chemical screens have to be small, low-cost and compatible with simple culture conditions to be suitable for high-throughput screening [27] . Xenopus meets these requirements as its fertilization and embryonic development is external and they produce a large number of transparent embryos that are small enough to be placed in 48-or 96-well plates.
The cumulative survival of the embryos after 96 h exposure with the liposomes is summarized in Figure 5 . Liposomes containing no 12-bis-THA did not cause any toxicity to the larvae even after incubation at the highest dose (2.65 mM lipids). As seen with the eukaryotic cell model, the addition of 12-bis-THA into the liposomes strongly increased the formulation toxicity but no differences were observed between the 12-bis-THA-loaded liposomes and the 12-bis-THA- Figure S6 ). Representative images show that the surviving embryos had no pattern of malformation or any visible phenotype related to toxicity (oedema, lack of pigmentation, bent spine, etc.) [48] . In summary these biological data indicate that the liposomal formulations retain antimicrobial activity and maintain a favourable in vitro activity-to-toxicity ratio (therapeutic index) [49] whilst improving the pharmaceutical properties of the nanoplexes. 
